Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
Top Cited Papers
Open Access
- 10 October 2002
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (15), 1143-1150
- https://doi.org/10.1056/nejmoa021274
Abstract
The use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism remains controversial.Keywords
This publication has 27 references indexed in Scilit:
- Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?Archives of Internal Medicine, 1997
- Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography.Heart, 1993
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJournal of the American College of Cardiology, 1992
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATORThe Lancet, 1986
- The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary diseaseThe American Journal of Cardiology, 1971
- Aortic atresia. Diagnostic cardiac catheterization in first week of life.Heart, 1971